| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 8.19e-11 | 10 | 174 | 6 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 8.19e-11 | 10 | 174 | 6 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 6.55e-10 | 13 | 174 | 6 | GO:0016713 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 9.82e-10 | 7 | 174 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 9.82e-10 | 7 | 174 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 9.41e-09 | 49 | 174 | 8 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.15e-08 | 10 | 174 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.85e-08 | 35 | 174 | 7 | GO:0070330 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 4.75e-08 | 24 | 174 | 6 | GO:0008392 | |
| GeneOntologyMolecularFunction | monooxygenase activity | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 6.60e-08 | 115 | 174 | 10 | GO:0004497 |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.02e-07 | 27 | 174 | 6 | GO:0008391 | |
| GeneOntologyMolecularFunction | iron ion binding | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 ETHE1 CYP4F22 CYP4F3 CYP4F11 | 2.01e-06 | 166 | 174 | 10 | GO:0005506 |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 6.42e-06 | 5 | 174 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | arachidonate binding | 7.05e-06 | 15 | 174 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V0A1 HSP90AB4P DNAH10 ABCA13 MYO10 RNF213 MYO1B CCT4 ATP9B SMC5 ABCA8 ABCC6 ABCA5 SHPRH SMARCA4 MACF1 KIF13A SNRNP200 | 7.33e-06 | 614 | 174 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 8.06e-06 | 194 | 174 | 10 | GO:0016705 |
| GeneOntologyMolecularFunction | heme binding | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 8.45e-06 | 154 | 174 | 9 | GO:0020037 |
| GeneOntologyMolecularFunction | icosanoid binding | 9.34e-06 | 16 | 174 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 9.34e-06 | 16 | 174 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.40e-05 | 164 | 174 | 9 | GO:0046906 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.44e-05 | 40 | 174 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90AB4P DNAH10 ABCA13 RNF213 CCT4 ATP9B SMC5 ABCA8 ABCC6 ABCA5 SMARCA4 MACF1 KIF13A SNRNP200 | 3.37e-05 | 441 | 174 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | transition metal ion binding | CYP4V2 UBR1 ABL1 KMT2B PITRM1 TRIM42 CYP4Z1 TNFSF10 CYP4A11 CYP4B1 CYP4F2 MEFV CYP4A22 MEP1B BRCA1 USP51 ETHE1 TLL2 CYP4F22 CYP4F3 MMP14 MMP17 L3MBTL3 CYP4F11 TRIM37 | 3.84e-05 | 1189 | 174 | 25 | GO:0046914 |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 7.55e-05 | 2 | 174 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 7.55e-05 | 2 | 174 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 7.55e-05 | 2 | 174 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 7.55e-05 | 2 | 174 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 9.68e-05 | 28 | 174 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.10e-04 | 138 | 174 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.51e-04 | 107 | 174 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.46e-04 | 120 | 174 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.69e-04 | 49 | 174 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.11e-03 | 6 | 174 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 1.11e-03 | 6 | 174 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.21e-03 | 239 | 174 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 1.54e-03 | 7 | 174 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | L-leucine binding | 1.54e-03 | 7 | 174 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.78e-03 | 254 | 174 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.86e-03 | 316 | 174 | 9 | GO:0035091 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.89e-03 | 200 | 174 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.67e-03 | 109 | 174 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 IDH1 GFUS SESN1 CYP4A22 ETHE1 CYP4F22 CYP4F3 HADHB CYP4F11 | 2.94e-03 | 766 | 174 | 15 | GO:0016491 |
| GeneOntologyMolecularFunction | fatty acid binding | 3.10e-03 | 69 | 174 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.19e-03 | 34 | 174 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSP90AB4P DNAH10 ABCA13 RNF213 CCT4 ATP9B SMC5 GEM ABCA8 ABCC6 ABCA5 SMARCA4 MACF1 KIF13A SNRNP200 | 3.28e-03 | 775 | 174 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | actin filament binding | 3.83e-03 | 227 | 174 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | integrin binding | 4.38e-03 | 175 | 174 | 6 | GO:0005178 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.41e-08 | 6 | 175 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.72e-07 | 7 | 175 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 3.41e-07 | 8 | 175 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 6.00e-07 | 3 | 175 | 3 | GO:0048252 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.58e-06 | 11 | 175 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.35e-06 | 12 | 175 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 4.69e-06 | 14 | 175 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | CYP4V2 ACACB CYP4Z1 CYP4A11 CYP4B1 ANKRD26 GPAM CYP4F2 CYP4A22 BRCA1 CYP4F3 HADHB PCCB CYP4F11 EIF2AK3 | 9.63e-06 | 461 | 175 | 15 | GO:0006631 |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 1.46e-05 | 129 | 175 | 8 | GO:1905954 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP4V2 ACACB CYP4Z1 CYP4A11 CYP4B1 ANKRD26 HLCS GPAM CYP4F2 IDH1 IDUA KYAT1 CYP4A22 BRCA1 CYP4F3 HADHB PCCB CYP4F11 EIF2AK3 | 1.52e-05 | 731 | 175 | 19 | GO:0032787 |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.42e-05 | 68 | 175 | 6 | GO:0019369 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.25e-05 | 22 | 175 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 3.39e-05 | 145 | 175 | 8 | GO:0072329 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 6.02e-05 | 116 | 175 | 7 | GO:0009062 | |
| GeneOntologyBiologicalProcess | oxylipin metabolic process | 7.16e-05 | 2 | 175 | 2 | GO:0031407 | |
| GeneOntologyBiologicalProcess | oxylipin biosynthetic process | 7.16e-05 | 2 | 175 | 2 | GO:0031408 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 9.50e-05 | 215 | 175 | 9 | GO:1905952 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.08e-04 | 270 | 175 | 10 | GO:0007160 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | ACACB CYP4A11 MAT1A CYP4F2 IDUA KYAT1 CYP4F3 HADHB PCCB CYP4F11 | 1.14e-04 | 272 | 175 | 10 | GO:0016054 |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | ACACB CYP4A11 MAT1A CYP4F2 IDUA KYAT1 CYP4F3 HADHB PCCB CYP4F11 | 1.14e-04 | 272 | 175 | 10 | GO:0046395 |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.26e-04 | 91 | 175 | 6 | GO:0033627 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP4V2 ACACB CYP4Z1 CYP4A11 CYP4B1 MAT1A ANKRD26 HLCS GPAM CYP4F2 IDH1 IDUA KYAT1 CYP4A22 BRCA1 CYP4F22 CYP4F3 HADHB PCCB CYP4F11 EIF2AK3 | 1.92e-04 | 1035 | 175 | 21 | GO:0019752 |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.13e-04 | 142 | 175 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 2.14e-04 | 3 | 175 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 2.53e-04 | 15 | 175 | 3 | GO:0051791 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP4V2 ACACB CYP4Z1 CYP4A11 CYP4B1 MAT1A ANKRD26 HLCS GPAM CYP4F2 IDH1 IDUA KYAT1 CYP4A22 BRCA1 CYP4F22 CYP4F3 HADHB PCCB CYP4F11 EIF2AK3 | 2.58e-04 | 1058 | 175 | 21 | GO:0043436 |
| GeneOntologyBiologicalProcess | small molecule catabolic process | ACACB CYP4A11 MAT1A CYP4F2 IDUA KYAT1 SCARB1 LRP5 CYP4F3 HADHB PCCB CYP4F11 | 2.63e-04 | 421 | 175 | 12 | GO:0044282 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP4V2 ACACB CYP4Z1 CYP4A11 CYP4B1 MAT1A ANKRD26 HLCS GPAM CYP4F2 IDH1 IDUA KYAT1 CYP4A22 BRCA1 CYP4F22 CYP4F3 HADHB PCCB CYP4F11 EIF2AK3 | 2.78e-04 | 1064 | 175 | 21 | GO:0006082 |
| GeneOntologyBiologicalProcess | post-translational protein modification | UBR1 MED6 ABL1 TRIM42 PELI3 OTUB1 HLCS RNF213 SMC5 MEFV STAMBP THOP1 BRCA1 USP51 TULP4 RNF103 CDC16 SHPRH WDSUB1 KLHL18 TRIM37 | 3.15e-04 | 1074 | 175 | 21 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | UBR1 MED6 ABL1 TRIM42 PELI3 OTUB1 RNF213 SMC5 MEFV STAMBP THOP1 BRCA1 USP51 TULP4 RNF103 CDC16 SHPRH WDSUB1 KLHL18 TRIM37 | 3.71e-04 | 1009 | 175 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.91e-04 | 73 | 175 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | AADAC ATP6V0A1 ABL1 ACACB CYP4A11 MAT1A ATG13 RNF213 CYP4F2 IDH1 IDUA WDFY4 SESN1 MEFV KYAT1 THOP1 SCARB1 ELAPOR1 LAMP3 CYP4F3 HADHB PCCB CYP4F11 | 3.96e-04 | 1253 | 175 | 23 | GO:0044248 |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 3.97e-04 | 41 | 175 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 4.25e-04 | 4 | 175 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 4.25e-04 | 4 | 175 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 4.25e-04 | 4 | 175 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 4.25e-04 | 4 | 175 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | AADAC ACACB CYP4A11 CYP4F2 IDH1 CIDEA SCARB1 CYP4F3 HADHB PCCB CYP4F11 | 4.36e-04 | 382 | 175 | 11 | GO:0016042 |
| GeneOntologyBiologicalProcess | regulation of lipid catabolic process | 5.32e-04 | 78 | 175 | 5 | GO:0050994 | |
| GeneOntologyCellularComponent | integrin complex | 1.42e-04 | 32 | 175 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | fatty acid beta-oxidation multienzyme complex | 2.08e-04 | 3 | 175 | 2 | GO:0036125 | |
| GeneOntologyCellularComponent | mitochondrial fatty acid beta-oxidation multienzyme complex | 2.08e-04 | 3 | 175 | 2 | GO:0016507 | |
| HumanPheno | Abnormal epiglottis morphology | 7.55e-06 | 23 | 64 | 5 | HP:0005483 | |
| Domain | Cyt_P450_E_grp-I | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.85e-10 | 45 | 174 | 9 | IPR002401 |
| Domain | Cyt_P450_CS | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.34e-09 | 53 | 174 | 9 | IPR017972 |
| Domain | CYTOCHROME_P450 | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.63e-09 | 57 | 174 | 9 | PS00086 |
| Domain | - | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 3.09e-09 | 58 | 174 | 9 | 1.10.630.10 |
| Domain | p450 | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 3.09e-09 | 58 | 174 | 9 | PF00067 |
| Domain | Cyt_P450 | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 4.22e-09 | 60 | 174 | 9 | IPR001128 |
| Domain | Integrin_dom | 7.90e-05 | 25 | 174 | 4 | IPR032695 | |
| Domain | PIEZO | 8.63e-05 | 2 | 174 | 2 | PF15917 | |
| Domain | Piezo | 8.63e-05 | 2 | 174 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 8.63e-05 | 2 | 174 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 8.63e-05 | 2 | 174 | 2 | IPR031334 | |
| Domain | Piezo_dom | 8.63e-05 | 2 | 174 | 2 | IPR031805 | |
| Domain | VWFA | 1.17e-04 | 82 | 174 | 6 | PS50234 | |
| Domain | VWA | 1.34e-04 | 84 | 174 | 6 | SM00327 | |
| Domain | Peptidase_Metallo | 1.44e-04 | 29 | 174 | 4 | IPR006026 | |
| Domain | ZnMc | 1.44e-04 | 29 | 174 | 4 | SM00235 | |
| Domain | EGF-like_Ca-bd_dom | 1.63e-04 | 124 | 174 | 7 | IPR001881 | |
| Domain | ABC_A | 1.64e-04 | 12 | 174 | 3 | IPR026082 | |
| Domain | BPS-dom | 2.57e-04 | 3 | 174 | 2 | IPR015042 | |
| Domain | BPS | 2.57e-04 | 3 | 174 | 2 | PF08947 | |
| Domain | Ldl_recept_b | 2.68e-04 | 14 | 174 | 3 | PF00058 | |
| Domain | LDLRB | 2.68e-04 | 14 | 174 | 3 | PS51120 | |
| Domain | VWF_A | 3.28e-04 | 99 | 174 | 6 | IPR002035 | |
| Domain | LY | 3.33e-04 | 15 | 174 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.33e-04 | 15 | 174 | 3 | IPR000033 | |
| Domain | Znf_RING/FYVE/PHD | UBR1 KMT2B TRIM42 BAZ2B RNF213 DIDO1 ZFYVE9 BRCA1 USP51 RNF103 SHPRH WDSUB1 TRIM37 | 3.80e-04 | 459 | 174 | 13 | IPR013083 |
| Domain | AAA | 4.07e-04 | 144 | 174 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 4.07e-04 | 144 | 174 | 7 | IPR003593 | |
| Domain | - | 4.64e-04 | 39 | 174 | 4 | 2.120.10.30 | |
| Domain | Carboxyl_trans | 5.11e-04 | 4 | 174 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 5.11e-04 | 4 | 174 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 5.11e-04 | 4 | 174 | 2 | PS50980 | |
| Domain | COA_CT_N | 5.11e-04 | 4 | 174 | 2 | IPR011762 | |
| Domain | COA_CT_C | 5.11e-04 | 4 | 174 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 5.11e-04 | 4 | 174 | 2 | IPR000022 | |
| Domain | Integrin_alpha-2 | 5.85e-04 | 18 | 174 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 5.85e-04 | 18 | 174 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 5.85e-04 | 18 | 174 | 3 | PF08441 | |
| Domain | Integrin_alpha | 5.85e-04 | 18 | 174 | 3 | IPR000413 | |
| Domain | Int_alpha | 6.90e-04 | 19 | 174 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 6.90e-04 | 19 | 174 | 3 | IPR013519 | |
| Domain | EGF-like_CS | 7.81e-04 | 261 | 174 | 9 | IPR013032 | |
| Domain | YD | 8.47e-04 | 5 | 174 | 2 | IPR006530 | |
| Domain | EGF_2 | 8.70e-04 | 265 | 174 | 9 | PS01186 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.75e-04 | 46 | 174 | 4 | IPR011042 | |
| Domain | - | 9.59e-04 | 81 | 174 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 9.59e-04 | 81 | 174 | 5 | IPR024079 | |
| Domain | EGF_CA | 9.94e-04 | 122 | 174 | 6 | SM00179 | |
| Domain | ABC_tran | 1.03e-03 | 48 | 174 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.03e-03 | 48 | 174 | 4 | PS50893 | |
| Domain | - | UBR1 KMT2B BAZ2B RNF213 DIDO1 ZFYVE9 BRCA1 USP51 RNF103 SHPRH WDSUB1 TRIM37 | 1.05e-03 | 449 | 174 | 12 | 3.30.40.10 |
| Domain | FG_GAP | 1.07e-03 | 22 | 174 | 3 | PS51470 | |
| Domain | Quino_amine_DH_bsu | 1.07e-03 | 22 | 174 | 3 | IPR011044 | |
| Domain | ABC_TRANSPORTER_1 | 1.11e-03 | 49 | 174 | 4 | PS00211 | |
| Domain | EGF | 1.17e-03 | 126 | 174 | 6 | PF00008 | |
| Domain | ABC_transporter-like | 1.20e-03 | 50 | 174 | 4 | IPR003439 | |
| Domain | Peptidase_M12A | 1.26e-03 | 6 | 174 | 2 | IPR001506 | |
| Domain | Astacin | 1.26e-03 | 6 | 174 | 2 | PF01400 | |
| Domain | FG-GAP | 1.39e-03 | 24 | 174 | 3 | PF01839 | |
| Domain | FG-GAP | 1.39e-03 | 24 | 174 | 3 | IPR013517 | |
| Domain | EGF | 1.65e-03 | 235 | 174 | 8 | SM00181 | |
| Domain | EGF_3 | 1.65e-03 | 235 | 174 | 8 | PS50026 | |
| Domain | Yip1 | 1.76e-03 | 7 | 174 | 2 | IPR006977 | |
| Domain | Yip1 | 1.76e-03 | 7 | 174 | 2 | PF04893 | |
| Domain | VWA | 1.83e-03 | 56 | 174 | 4 | PF00092 | |
| Domain | ZINC_PROTEASE | 2.24e-03 | 98 | 174 | 5 | PS00142 | |
| Domain | EGF_CA | 2.34e-03 | 99 | 174 | 5 | PS01187 | |
| Domain | EGF-like_dom | 2.37e-03 | 249 | 174 | 8 | IPR000742 | |
| Domain | EGF_1 | 2.74e-03 | 255 | 174 | 8 | PS00022 | |
| Pathway | REACTOME_EICOSANOIDS | 5.07e-12 | 12 | 136 | 7 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.07e-12 | 12 | 136 | 7 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 5.07e-12 | 12 | 136 | 7 | MM14845 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.02e-11 | 15 | 136 | 7 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.94e-10 | 18 | 136 | 7 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.94e-10 | 18 | 136 | 7 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.92e-10 | 21 | 136 | 7 | M27137 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.77e-09 | 25 | 136 | 7 | MM14858 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 7.30e-09 | 62 | 136 | 9 | M39653 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.45e-07 | 14 | 136 | 5 | MM15842 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.71e-07 | 64 | 136 | 8 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.19e-07 | 66 | 136 | 8 | MM14839 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | CYP4V2 AADAC CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 7.02e-07 | 104 | 136 | 9 | M738 |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | CYP4V2 AADAC CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 7.62e-07 | 105 | 136 | 9 | MM14842 |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.50e-06 | 59 | 136 | 7 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.88e-06 | 61 | 136 | 7 | MM14861 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 2.60e-06 | 11 | 136 | 4 | MM14863 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | ACACB CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 HADHB PCCB CYP4F11 | 5.74e-06 | 170 | 136 | 10 | MM15573 |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | ACACB CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 HADHB PCCB CYP4F11 | 7.81e-06 | 176 | 136 | 10 | M27854 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.48e-05 | 33 | 136 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.48e-05 | 33 | 136 | 5 | MM15963 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP4V2 AADAC CYP4A11 CYP4B1 MAT1A CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 5.15e-05 | 219 | 136 | 10 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP4V2 AADAC CYP4A11 CYP4B1 MAT1A CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 5.36e-05 | 220 | 136 | 10 | M10320 |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 5.57e-05 | 43 | 136 | 5 | MM15873 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 7.07e-05 | 9 | 136 | 3 | M39819 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 7.07e-05 | 9 | 136 | 3 | M40064 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.05e-04 | 26 | 136 | 4 | M47 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.37e-04 | 11 | 136 | 3 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.37e-04 | 11 | 136 | 3 | MM14764 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.29e-04 | 76 | 136 | 5 | MM14867 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 8.34e-04 | 44 | 136 | 4 | M11911 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.90e-04 | 258 | 136 | 9 | MM14572 | |
| Pubmed | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.03e-10 | 70 | 179 | 9 | 15128046 | |
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 9068972 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABL1 GBF1 KMT2B MYO10 PIEZO1 MYOM3 PPP6R1 LRRK1 IDUA MADD CELSR1 SARS2 STX4 PSME4 TULP4 BTBD7 SCARB1 LRP5 MMP14 MMP17 WNK2 AHNAK2 | 6.72e-08 | 1105 | 179 | 22 | 35748872 |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 1.34e-07 | 3 | 179 | 3 | 15145985 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 9271096 | ||
| Pubmed | GBF1 BAZ2B ANKRD26 RNF213 GPAM WDFY4 ABCA8 TULP4 ELAPOR1 WDR35 MACF1 SNRNP200 KLHL18 TANGO6 | 3.09e-07 | 493 | 179 | 14 | 15368895 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 5.34e-07 | 4 | 179 | 3 | 18065749 | |
| Pubmed | 3.08e-06 | 20 | 179 | 4 | 21689717 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 3.15e-06 | 44 | 179 | 5 | 12745259 | |
| Pubmed | 7.72e-06 | 193 | 179 | 8 | 19343046 | ||
| Pubmed | MYO10 ATG13 SYNE1 PPP6R1 SMC5 TENM2 MADD CADPS BTBD7 MACF1 SLC9A6 | 9.43e-06 | 407 | 179 | 11 | 12693553 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.09e-05 | 27 | 179 | 4 | 31541017 | |
| Pubmed | Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening. | 1.61e-05 | 61 | 179 | 5 | 35205757 | |
| Pubmed | 1.63e-05 | 214 | 179 | 8 | 22199357 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GBF1 SRSF5 ABCA13 PKD1L1 CALCOCO1 DIDO1 SLFN5 STK31 MACF1 CPLANE1 | 1.96e-05 | 361 | 179 | 10 | 26167880 |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16686598 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 35533267 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15611369 | ||
| Pubmed | Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. | 2.63e-05 | 2 | 179 | 2 | 20130494 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22462553 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 2.63e-05 | 2 | 179 | 2 | 21299953 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25734770 | ||
| Pubmed | OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression. | 2.63e-05 | 2 | 179 | 2 | 34488924 | |
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 2.63e-05 | 2 | 179 | 2 | 38395992 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 37820892 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25205731 | ||
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 2.63e-05 | 2 | 179 | 2 | 39251883 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17803681 | ||
| Pubmed | Crosstalk Between CD11b and Piezo1 Mediates Macrophage Responses to Mechanical Cues. | 2.63e-05 | 2 | 179 | 2 | 34630381 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24447304 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18391101 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 37975162 | ||
| Pubmed | Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143. | 2.63e-05 | 2 | 179 | 2 | 17478512 | |
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.63e-05 | 2 | 179 | 2 | 23641057 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31395659 | ||
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 2.63e-05 | 2 | 179 | 2 | 28636944 | |
| Pubmed | Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. | 2.63e-05 | 2 | 179 | 2 | 12024016 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34606908 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 28912346 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24413902 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25037583 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 8031839 | ||
| Pubmed | Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. | 2.63e-05 | 2 | 179 | 2 | 9799565 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 20085763 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 10860550 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18574070 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 2.63e-05 | 2 | 179 | 2 | 36717101 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11607834 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 2.63e-05 | 2 | 179 | 2 | 11320253 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 29484037 | ||
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 2.63e-05 | 2 | 179 | 2 | 32142647 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 33262312 | ||
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 2.63e-05 | 2 | 179 | 2 | 12464262 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34464353 | ||
| Pubmed | Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. | 2.63e-05 | 2 | 179 | 2 | 21540472 | |
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 2.63e-05 | 2 | 179 | 2 | 15066132 | |
| Pubmed | Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. | 2.63e-05 | 2 | 179 | 2 | 18433732 | |
| Pubmed | MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. | 2.63e-05 | 2 | 179 | 2 | 23457619 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24138531 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23825080 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23325923 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16691295 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 3829886 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 2.63e-05 | 2 | 179 | 2 | 8026587 | |
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 2.63e-05 | 2 | 179 | 2 | 29277328 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21820496 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 35068350 | ||
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 2.63e-05 | 2 | 179 | 2 | 20943934 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 30324494 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 2766933 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15364545 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21056836 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 30745454 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 2.63e-05 | 2 | 179 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 2.63e-05 | 2 | 179 | 2 | 27743844 | |
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 2.63e-05 | 2 | 179 | 2 | 38928429 | |
| Pubmed | Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis. | 2.63e-05 | 2 | 179 | 2 | 33627137 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 2.63e-05 | 2 | 179 | 2 | 26008989 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17112342 | ||
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 2.63e-05 | 2 | 179 | 2 | 20813920 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 26959478 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15351710 | ||
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 2.63e-05 | 2 | 179 | 2 | 30088983 | |
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 2.63e-05 | 2 | 179 | 2 | 19208908 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACB U2SURP ANKRD26 HLCS CCDC50 DIDO1 MYO1B CCT4 PPP6R1 IDH1 TRIP11 BUB1B SMARCA4 MACF1 SNRNP200 AHNAK2 | 2.91e-05 | 934 | 179 | 16 | 33916271 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT5 ACACB ATG13 PKD1L1 ANKRD26 HLCS DYNC2I1 CCDC50 CCT4 CEP128 BUB1B CPLANE1 PCCB TRIM37 BORA | 3.88e-05 | 853 | 179 | 15 | 28718761 |
| Pubmed | A role for smoothened during murine lens and cornea development. | 5.83e-05 | 15 | 179 | 3 | 25268479 | |
| Pubmed | 6.01e-05 | 130 | 179 | 6 | 12421765 | ||
| Pubmed | Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. | 7.88e-05 | 3 | 179 | 2 | 2354437 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 23438604 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 27373334 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 23294542 | ||
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 7.88e-05 | 3 | 179 | 2 | 28270609 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 15034933 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 21795642 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 29521261 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 19324882 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 19454683 | ||
| Pubmed | Dual role of Brg chromatin remodeling factor in Sonic hedgehog signaling during neural development. | 7.88e-05 | 3 | 179 | 2 | 21768360 | |
| Interaction | NXPH2 interactions | 3.02e-07 | 33 | 170 | 6 | int:NXPH2 | |
| Cytoband | 2q24.2 | 8.50e-05 | 22 | 179 | 3 | 2q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 9.80e-05 | 61 | 179 | 4 | chr1p33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.47e-04 | 127 | 179 | 5 | chr2q24 | |
| Cytoband | 1p33 | 3.48e-04 | 35 | 179 | 3 | 1p33 | |
| Cytoband | 15q26.3 | 5.57e-04 | 41 | 179 | 3 | 15q26.3 | |
| GeneFamily | Cytochrome P450 family 4 | CYP4V2 CYP4Z1 CYP4A11 CYP4B1 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.01e-12 | 36 | 124 | 9 | 1003 |
| GeneFamily | ATP binding cassette subfamily A | 1.08e-04 | 14 | 124 | 3 | 805 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.38e-04 | 18 | 124 | 3 | 1160 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 6.87e-04 | 6 | 124 | 2 | 894 | |
| GeneFamily | Yip1 domain containing | 9.58e-04 | 7 | 124 | 2 | 105 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | AADAC CYP4A11 MAT1A MYO1B CYP4F2 ABCA8 CYP4A22 CYP4F3 CYP4F11 | 3.78e-06 | 179 | 177 | 9 | M16932 |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | KRT5 ABCA13 CYP4B1 MUC16 MYO1B ITGB6 CELSR1 ELAPOR1 LAMP3 PLXNB1 | 8.56e-09 | 200 | 178 | 10 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-08 | 169 | 178 | 9 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-08 | 169 | 178 | 9 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-08 | 122 | 178 | 8 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DNAH10 ABCA13 CYP4B1 GLIS3 DYNC2I1 CELSR1 CPLANE1 WDR49 AHNAK2 | 8.80e-08 | 193 | 178 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-07 | 197 | 178 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 198 | 178 | 9 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.31e-07 | 164 | 178 | 8 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.66e-07 | 176 | 178 | 8 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.91e-07 | 177 | 178 | 8 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.13e-06 | 193 | 178 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 195 | 178 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.32e-06 | 197 | 178 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 198 | 178 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.48e-06 | 200 | 178 | 8 | a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-06 | 200 | 178 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-06 | 166 | 178 | 7 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.42e-06 | 169 | 178 | 7 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 6.56e-06 | 174 | 178 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 182 | 178 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.45e-06 | 184 | 178 | 7 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 185 | 178 | 7 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 185 | 178 | 7 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 185 | 178 | 7 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 187 | 178 | 7 | 82bbc107f58c623f3b90430c90c562624a12abef | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 187 | 178 | 7 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 178 | 7 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 190 | 178 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 191 | 178 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 178 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 192 | 178 | 7 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 192 | 178 | 7 | 2360824910cd471c8286ca369ba144d90d984602 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 192 | 178 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 193 | 178 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 193 | 178 | 7 | ac1073bf4d3868841226b850b058f1e27326a14e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 194 | 178 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 194 | 178 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 194 | 178 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 195 | 178 | 7 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 195 | 178 | 7 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-05 | 196 | 178 | 7 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 196 | 178 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-05 | 196 | 178 | 7 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.42e-05 | 196 | 178 | 7 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 131 | 178 | 6 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 178 | 7 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 197 | 178 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 197 | 178 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 197 | 178 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 198 | 178 | 7 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 198 | 178 | 7 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 198 | 178 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 198 | 178 | 7 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.52e-05 | 198 | 178 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 198 | 178 | 7 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 198 | 178 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 198 | 178 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.57e-05 | 199 | 178 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 199 | 178 | 7 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-05 | 200 | 178 | 7 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.62e-05 | 200 | 178 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.62e-05 | 200 | 178 | 7 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 139 | 178 | 6 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 139 | 178 | 6 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-05 | 144 | 178 | 6 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 151 | 178 | 6 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 3.92e-05 | 156 | 178 | 6 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-05 | 157 | 178 | 6 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-05 | 157 | 178 | 6 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 158 | 178 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 158 | 178 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.36e-05 | 159 | 178 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-05 | 162 | 178 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-05 | 162 | 178 | 6 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.84e-05 | 162 | 178 | 6 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.36e-05 | 165 | 178 | 6 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-05 | 165 | 178 | 6 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-05 | 165 | 178 | 6 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| Drug | propoxyphene | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.45e-09 | 67 | 177 | 9 | CID000010100 |
| Drug | carteolol | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 4.73e-09 | 72 | 177 | 9 | CID000002583 |
| Drug | trimipramine | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.22e-08 | 80 | 177 | 9 | CID000005584 |
| Drug | diosmetin | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.10e-08 | 85 | 177 | 9 | CID005281612 |
| Drug | mephenytoin | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.85e-08 | 88 | 177 | 9 | CID000004060 |
| Drug | 8-MOP | ZNF143 CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.95e-08 | 118 | 177 | 10 | CID000004114 |
| Drug | tienilic acid | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 4.64e-08 | 93 | 177 | 9 | CID000038409 |
| Drug | lansoprazole | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 4.64e-08 | 93 | 177 | 9 | CID000003883 |
| Drug | AC1L1KIN | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 8.77e-08 | 100 | 177 | 9 | CID000005516 |
| Drug | Sparteinum | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 9.56e-08 | 101 | 177 | 9 | CID000003966 |
| Drug | AC1Q7AUJ | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 3.40e-07 | 117 | 177 | 9 | CID000003303 |
| Drug | paraoxon | AADAC CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 6.53e-07 | 164 | 177 | 10 | CID000009395 |
| Drug | hexobarbital | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 6.83e-07 | 127 | 177 | 9 | CID000003608 |
| Drug | chloral hydrate | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 7.79e-07 | 129 | 177 | 9 | CID000002707 |
| Drug | felodipine | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 EGF CYP4F22 CYP4F3 CYP4F11 | 8.60e-07 | 169 | 177 | 10 | CID000003333 |
| Drug | aminopyrine | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 EGF CYP4F22 CYP4F3 CYP4F11 | 9.58e-07 | 171 | 177 | 10 | CID000006009 |
| Drug | aminoglutethimide | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.29e-06 | 137 | 177 | 9 | CID000002145 |
| Drug | heliotrine | 1.90e-06 | 48 | 177 | 6 | ctd:C010178 | |
| Drug | diclofenac | KRT5 CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 5.81e-06 | 209 | 177 | 10 | CID000003032 |
| Drug | senkirkine | 7.90e-06 | 61 | 177 | 6 | ctd:C009238 | |
| Drug | metyrapone | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 1.16e-05 | 179 | 177 | 9 | CID000004174 |
| Drug | dioxin | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 EGF BRCA1 HPS4 CYP4F22 CYP4F3 CYP4F11 | 1.85e-05 | 347 | 177 | 12 | CID000015625 |
| Drug | alprazolam | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.11e-05 | 193 | 177 | 9 | CID000002118 |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 7252_UP | |
| Drug | senecionine | 2.42e-05 | 74 | 177 | 6 | ctd:C009237 | |
| Drug | tolbutamide | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 CYP4A22 CYP4F22 CYP4F3 CYP4F11 | 2.58e-05 | 198 | 177 | 9 | CID000005505 |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HG-U133A | 2.58e-05 | 198 | 177 | 9 | 665_UP | |
| Drug | phenobarbital | CYP4Z1 CYP4A11 CYP4B1 COQ6 CYP4F2 ABCC6 CYP4A22 EGF CYP4F22 CYP4F3 CYP4F11 TRIM37 | 2.66e-05 | 360 | 177 | 12 | CID000004763 |
| Drug | Biotin | 3.75e-05 | 9 | 177 | 3 | DB00121 | |
| Drug | 19-HETE | 3.88e-05 | 49 | 177 | 5 | CID006439528 | |
| Drug | N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide | 6.01e-05 | 2 | 177 | 2 | ctd:C503100 | |
| Drug | Wy-14,643 | AADAC CYP4Z1 CYP4A11 COQ6 GPAM CYP4A22 CIDEA ETHE1 CYP4F3 TRIM37 | 8.51e-05 | 286 | 177 | 10 | CID000005694 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | GBF1 ACACB DNAH10 ABCA8 MADD SCARB1 SMARCA4 MACF1 PCCB L3MBTL3 | 6.11e-06 | 276 | 174 | 10 | EFO_0004612, EFO_0020943 |
| Disease | 10-undecenoate 11:1n1 measurement | 6.93e-06 | 7 | 174 | 3 | EFO_0021099 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | ACACB DNAH10 PELI3 GRB14 GPAM ABCA8 SCARB1 SMARCA4 MACF1 PCCB | 9.70e-06 | 291 | 174 | 10 | EFO_0008317, EFO_0020946 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.51e-05 | 243 | 174 | 9 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | DNAH10 GRB14 GPAM ABCA8 MADD SCARB1 SMARCA4 PCCB L3MBTL3 TANGO6 | 1.77e-05 | 312 | 174 | 10 | EFO_0004612, EFO_0010351 |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | DNAH10 GRB14 GPAM ABCA8 MADD SCARB1 SMARCA4 PCCB L3MBTL3 TANGO6 | 1.92e-05 | 315 | 174 | 10 | EFO_0004574, EFO_0004612 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.62e-05 | 200 | 174 | 8 | EFO_0004611, EFO_0020945 | |
| Disease | vitamin E measurement | 1.03e-04 | 3 | 174 | 2 | EFO_0004867 | |
| Disease | cholesteryl ester measurement | 1.52e-04 | 257 | 174 | 8 | EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.82e-04 | 264 | 174 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.32e-04 | 206 | 174 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 2.48e-04 | 21 | 174 | 3 | DOID:4914 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 2.52e-04 | 277 | 174 | 8 | C0009404 | |
| Disease | Colorectal Carcinoma | TNFSF10 ABCA13 SYNE1 MYO1B IDH1 ABCA8 ABCC6 ABCA5 GLI3 BUB1B SNRNP200 WDR49 MAF | 2.87e-04 | 702 | 174 | 13 | C0009402 |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 3.42e-04 | 5 | 174 | 2 | C0432197 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.84e-04 | 224 | 174 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | phospholipids:total lipids ratio | 4.16e-04 | 227 | 174 | 7 | EFO_0020946 | |
| Disease | X-14939 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0800747 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.65e-04 | 239 | 174 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | hereditary lymphedema (is_implicated_in) | 7.12e-04 | 7 | 174 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | octadecanedioylcarnitine (C18-DC) measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0800371 | |
| Disease | gallbladder cancer (is_marker_for) | 7.12e-04 | 7 | 174 | 2 | DOID:3121 (is_marker_for) | |
| Disease | X-18899 measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0800793 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 8.00e-04 | 330 | 174 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | X-12063 measurement | 8.53e-04 | 186 | 174 | 6 | EFO_0021283 | |
| Disease | very low density lipoprotein cholesterol measurement | 9.27e-04 | 260 | 174 | 7 | EFO_0008317 | |
| Disease | X-24748 measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0022136 | |
| Disease | Unilateral agenesis of kidney | 9.46e-04 | 8 | 174 | 2 | C0266294 | |
| Disease | pantothenate measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0021034 | |
| Disease | pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0800494 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.58e-04 | 127 | 174 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | hemoglobin A1 measurement | PIEZO1 GRB14 GSAP ITGAD MADD EGF TULP4 MACF1 L3MBTL3 SNRNP200 | 1.09e-03 | 520 | 174 | 10 | EFO_0007629 |
| Disease | non-high density lipoprotein cholesterol measurement | ATP6V0A1 DNAH10 GLIS3 GRB14 GPAM THOP1 STX4 SCARB1 SMARCA4 PCCB L3MBTL3 MAF | 1.13e-03 | 713 | 174 | 12 | EFO_0005689 |
| Disease | Disproportionate short stature | 1.13e-03 | 77 | 174 | 4 | C0878659 | |
| Disease | Mammary Carcinoma, Human | 1.17e-03 | 525 | 174 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.17e-03 | 525 | 174 | 10 | C1257931 | |
| Disease | fatty acid measurement | 1.19e-03 | 436 | 174 | 9 | EFO_0005110 | |
| Disease | Mammary Neoplasms | 1.21e-03 | 527 | 174 | 10 | C1458155 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.21e-03 | 9 | 174 | 2 | EFO_0800562 | |
| Disease | tetradecanedioate measurement | 1.21e-03 | 9 | 174 | 2 | EFO_0021057 | |
| Disease | Breast Carcinoma | 1.40e-03 | 538 | 174 | 10 | C0678222 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 1.51e-03 | 10 | 174 | 2 | DOID:7693 (is_marker_for) | |
| Disease | triglyceride measurement, phospholipid measurement | 1.78e-03 | 146 | 174 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | Malignant neoplasm of breast | NID2 KRT5 ABL1 TNFSF10 SYNE1 HLCS GRB7 EGF BRCA1 ELAPOR1 MACF1 HADHB MMP14 L3MBTL3 PLXNB1 | 1.81e-03 | 1074 | 174 | 15 | C0006142 |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.84e-03 | 11 | 174 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.01e-03 | 220 | 174 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.10e-03 | 222 | 174 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | diabetic angiopathy (is_marker_for) | 2.19e-03 | 12 | 174 | 2 | DOID:11713 (is_marker_for) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.20e-03 | 224 | 174 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.22e-03 | 303 | 174 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.25e-03 | 225 | 174 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.25e-03 | 225 | 174 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.39e-03 | 307 | 174 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.45e-03 | 229 | 174 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | central corneal thickness | 2.47e-03 | 309 | 174 | 7 | EFO_0005213 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.58e-03 | 13 | 174 | 2 | C0036996 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 2.58e-03 | 13 | 174 | 2 | EFO_0800588 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.75e-03 | 315 | 174 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | Saldino-Noonan Syndrome | 3.00e-03 | 14 | 174 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.00e-03 | 14 | 174 | 2 | C0024507 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 3.06e-03 | 321 | 174 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.22e-03 | 50 | 174 | 3 | EFO_0022247 | |
| Disease | Liver carcinoma | 3.28e-03 | 507 | 174 | 9 | C2239176 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.28e-03 | 103 | 174 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Yu-Zhi constitution type | 3.45e-03 | 15 | 174 | 2 | EFO_0007638 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.45e-03 | 15 | 174 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.64e-03 | 106 | 174 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | testosterone measurement | VIL1 UBR1 TNFSF10 CYP4B1 GLIS3 FAXC GRB14 GPAM ABCA8 THOP1 SCARB1 LRP5 MACF1 PCCB L3MBTL3 MAF | 3.72e-03 | 1275 | 174 | 16 | EFO_0004908 |
| Disease | cutaneous Leishmaniasis | 3.93e-03 | 16 | 174 | 2 | EFO_0005046 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.15e-03 | 110 | 174 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.15e-03 | 110 | 174 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.15e-03 | 110 | 174 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | ecosanoids measurement | 4.22e-03 | 55 | 174 | 3 | EFO_0020044 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 4.22e-03 | 55 | 174 | 3 | EFO_0022288 | |
| Disease | Moyamoya Disease | 4.44e-03 | 17 | 174 | 2 | C0026654 | |
| Disease | lupus nephritis (is_marker_for) | 4.44e-03 | 17 | 174 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | biliary atresia | 4.44e-03 | 56 | 174 | 3 | MONDO_0008867 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 4.44e-03 | 56 | 174 | 3 | EFO_0022279 | |
| Disease | neuroimaging measurement | KMT2B GLIS3 IDUA NRP2 CELSR1 BRCA1 CADPS GLI3 MACF1 QSER1 L3MBTL3 EIF2AK3 WNK2 MAF | 4.53e-03 | 1069 | 174 | 14 | EFO_0004346 |
| Disease | free cholesterol in medium HDL measurement | 4.90e-03 | 58 | 174 | 3 | EFO_0022267 | |
| Disease | Carcinoma, Granular Cell | 5.01e-03 | 116 | 174 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.01e-03 | 116 | 174 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.01e-03 | 116 | 174 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.01e-03 | 116 | 174 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.01e-03 | 116 | 174 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.01e-03 | 116 | 174 | 4 | C0001418 | |
| Disease | cholesterol in medium HDL measurement | 5.14e-03 | 59 | 174 | 3 | EFO_0021903 | |
| Disease | Polydactyly | 5.16e-03 | 117 | 174 | 4 | C0152427 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in IDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022233 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022282 | |
| Disease | free cholesterol in HDL measurement | 5.65e-03 | 61 | 174 | 3 | EFO_0022264 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.81e-03 | 121 | 174 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 5.86e-03 | 274 | 174 | 6 | EFO_0004530, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVFSTHFMDEADILA | 666 | Q8WWZ7 | |
| AAEMNGVFDTTFQSH | 1016 | O60566 | |
| SSGNTHDDFVMIDFK | 436 | O75143 | |
| FVQETDDMTQLHGFH | 151 | Q6ZU80 | |
| MTDGEDADYTHFTNQ | 271 | Q8IVM0 | |
| SQFSPLEFSGMDHED | 736 | Q9NZJ5 | |
| HHFMDSFKVVGSFDE | 56 | P22760 | |
| FDASHSLRSVMFGQD | 1366 | Q9UIF8 | |
| DTFMFEGHDTTASGI | 316 | Q02928 | |
| ADHTDFIDTAGAMLQ | 301 | Q9Y2Z9 | |
| SFMSTEGQELEVIHT | 1046 | Q86UQ4 | |
| MEVSVSDGIHSVTAF | 1176 | Q9NYQ6 | |
| EFSFHGDLKTSQFEM | 1381 | Q9UPS8 | |
| VADAGSIFMDHFTDR | 191 | Q9H7Y0 | |
| FHTDFSNEENGTIMF | 116 | P00736 | |
| AGLTMNDIDAFEFHE | 366 | P55084 | |
| LMSFVEDHSNEFFTD | 6 | Q2TB18 | |
| HDFIGEFTSTFQEMQ | 236 | O95741 | |
| DIMIFFAEGFHGDST | 176 | P50281 | |
| VVTQTSGFAEMDHDL | 521 | O95199 | |
| ETMQAVEDGDSKSHF | 876 | Q2KHR3 | |
| LANIFAGVHDSMDSD | 91 | P55040 | |
| SSTSGQEFDVFSVMD | 6 | Q96JM7 | |
| DLSNAVHSEMFVGSD | 196 | Q6WBX8 | |
| EVTDSRSGNIMFHSF | 1666 | O00763 | |
| HAETFLSLFAVDMDA | 921 | Q9ULU8 | |
| DFTGHSLFDSDVDMD | 386 | Q5TGI0 | |
| AETILTFHAFAETMD | 361 | Q8WXI7 | |
| HTSMSEFILVGFSAF | 6 | O60403 | |
| MDGENHSVVSEFLFL | 1 | O95013 | |
| SGFFSEVSQDHETMA | 141 | Q9H079 | |
| FDAIIDDGDHSSLMS | 1506 | P10071 | |
| HAGTDTNGDIFFMEV | 1446 | Q8WXG6 | |
| HFDDRFSDEQLVTMS | 256 | O75444 | |
| LFVAAVDHSSSGDMS | 776 | Q96S38 | |
| DFSAMAFITDHVNSL | 1126 | Q38SD2 | |
| HTFQSGDEMTSLSEY | 366 | Q58FF6 | |
| QMDIHSFEGTFTRED | 306 | O43861 | |
| FFDAELSQMQTHVSD | 306 | P13647 | |
| EFEFDAATVSEHTML | 2201 | Q2LD37 | |
| NYTAVSSQDEDMGHF | 4001 | Q2LD37 | |
| DHIYTAAGASDNDFM | 456 | Q6UXG2 | |
| TGSHEDRMDSFFLAE | 451 | Q9BZQ6 | |
| HTADDEVKMDSFEFQ | 1496 | Q5SZK8 | |
| EAQEVEMASGHFAFL | 376 | Q9NQG7 | |
| RAFMNGSSVEHVVEF | 701 | O75197 | |
| TNMEAFSSEHFNLEI | 441 | P50747 | |
| FSTQEEMSGLSFHIA | 786 | Q8WVS4 | |
| EVEAFTFADHEMGSN | 3426 | Q5CZC0 | |
| TAVAVTMEDGHTIAF | 406 | O43157 | |
| TMEDGHTIAFLGDSQ | 411 | O43157 | |
| LVFVSDADSHFGMDS | 266 | P18564 | |
| MDEANHSVVSEFVFL | 1 | Q8NGB9 | |
| IHFDDFSLDVDAMIT | 611 | Q9HCR9 | |
| SSAHAGFFVEDNFMV | 361 | Q96HM7 | |
| SLTFHTDMAVAKDGF | 246 | O60462 | |
| SVEFAFMFEQAHEAV | 1801 | Q9HD67 | |
| KMPSSNIEEEDSHFF | 186 | Q8NC54 | |
| HSLSEGVFMFTSESV | 11 | Q00266 | |
| ARFMDGHITFQTAAT | 66 | Q9UQV4 | |
| EAMDFHGEVTFDTTK | 261 | Q13630 | |
| FDVVDATMHGNAARF | 2636 | Q9UMN6 | |
| QEHFFVASLEDVGQM | 476 | O15553 | |
| HSVVSEFVFMGLTNS | 6 | Q8NGB8 | |
| IAGNHELTFDQEFMA | 146 | O15442 | |
| SDTHFNGIVIMAFSS | 196 | Q8NGF4 | |
| TLHAFTFSSSMLGEE | 1461 | Q9C091 | |
| SASDNTLVAMDFSGH | 366 | Q14451 | |
| DSMDELFSHRSEIFG | 5726 | Q9UPN3 | |
| HDSQAFTSVDMEVGN | 6 | Q8NGQ1 | |
| RASSSFQHEMSQEGF | 341 | Q13349 | |
| FQHEMSQEGFSTALT | 346 | Q13349 | |
| TTMSGVAHRAFENDV | 251 | P05166 | |
| SLAGAAFTHDMEVTF | 606 | Q14112 | |
| TEFTIEDFHNTFMDL | 131 | Q96FW1 | |
| AAHTTDTAGYNAMEE | 1616 | P38398 | |
| NSRGSAAEFAVFHIM | 666 | A4D1B5 | |
| GHSFAVESEHDQAMA | 341 | Q13042 | |
| EEHMSLSQFFIEDFS | 226 | A8MPY1 | |
| DKSIEDFAHSSFQMA | 186 | O75874 | |
| SFIHQHFVEVSMSEE | 161 | O94889 | |
| FASMFDTIHAKDDSE | 546 | Q9H799 | |
| VDAGVSVIMDFHYNE | 71 | P01133 | |
| DFVSGIAFSIENSHM | 461 | Q6PGQ7 | |
| EADTFMFEGHDTTAS | 321 | Q9HBI6 | |
| DTFMFEGHDTTASGI | 316 | Q5TCH4 | |
| MGQASFDVFHRAFST | 711 | Q8NEA6 | |
| AVGVSMAHFSVSDAL | 1506 | Q9BTC0 | |
| FAEIHQAFETMFQES | 486 | P00519 | |
| FLETAEQHFMAGQSV | 121 | U3KPV4 | |
| EEVDTFMFEGHDTTA | 321 | Q6ZWL3 | |
| EADTFMFEGHDTTAS | 321 | P78329 | |
| AETMFTDLDSFVAFH | 741 | Q9P203 | |
| ELMGSASGHFTDFED | 131 | P35475 | |
| TFVLNDHSMAFTGDA | 141 | O95571 | |
| HAENESSFGLEMSQI | 361 | O75578 | |
| AAFVNGVAIHSMDFD | 81 | A6NK06 | |
| FVSLTEHDMASGDGN | 146 | Q9NQ30 | |
| NMADAVTHARFVGTD | 111 | Q92538 | |
| EHMVSFATETNGEIS | 206 | Q14449 | |
| RAEVDTFMFEGHDTT | 306 | P13584 | |
| FHFMADDIFSVNITD | 86 | Q9HBE5 | |
| EADTFMFEGHDTTAS | 321 | Q08477 | |
| SFHSADVLTMDDFGA | 361 | Q5H9B9 | |
| MIFLFTDAHVAEEGF | 2856 | Q8IVF4 | |
| NHTGEFISLQAMDSF | 301 | O00237 | |
| ALEDHMDGHFFFSTQ | 671 | Q9P1Z2 | |
| FMHFDSSSVNVGATA | 311 | Q16820 | |
| EIGHEAVSAFMNSSS | 436 | Q8TDX9 | |
| AVSAFMNSSSVHEDE | 441 | Q8TDX9 | |
| MNSSSVHEDEVLVFA | 446 | Q8TDX9 | |
| RAEADTFMFEGHDTT | 326 | Q6NT55 | |
| IDGSGSTQATDFHEM | 441 | A6NMZ7 | |
| ADAHSITTAAMEFGA | 1876 | A6NMZ7 | |
| TAVHGIQSAFDEAMS | 121 | O75586 | |
| FTHAFSSMESGVLVA | 121 | Q8NGH6 | |
| MDGENHSVVSEFLFL | 1 | Q6IEY1 | |
| TTNILEDHSFTEFMG | 1726 | Q9H1H9 | |
| GLGSDDTHFEVSMAN | 186 | Q5JXM2 | |
| MFQTEAGELQFAHTV | 436 | Q9NP81 | |
| EEHTSVGGFHDSFMV | 916 | O94972 | |
| FHSDVAMQDHVFVDT | 266 | Q8IWZ5 | |
| GSEDAQMHALFADSF | 61 | Q9Y6P5 | |
| AGDNSHTFDVTAMFK | 276 | Q92581 | |
| QLEDMAERFHFVSST | 481 | Q8NF91 | |
| ESAEENLKSHMEFFS | 5026 | Q8NF91 | |
| MEFFSTEDQFHSNLE | 5036 | Q8NF91 | |
| SFEEQHITFALDMDN | 1421 | Q5TAG4 | |
| TFRSSDAHGMDLFAV | 231 | Q9ULZ9 | |
| HMAETFQGSTVVRAF | 1126 | O95255 | |
| VDESLTMHFSTCEEF | 301 | Q8NE09 | |
| FQFHMFNDEDSVSLL | 1136 | Q5QGS0 | |
| EYTHDSDTDMFQIGR | 141 | Q8N2H9 | |
| AVEAFQHAVSGDFML | 46 | Q16773 | |
| FDLGFSGNSEDVVMH | 521 | Q9HCL2 | |
| DSHMDTYEQGVLFSS | 656 | Q5JRX3 | |
| MFQHIEESFSEHLGF | 1051 | P51532 | |
| HRFDVEFVDEGSTSM | 1311 | Q149N8 | |
| FAESGAMEGETLHTF | 416 | Q8WTV0 | |
| AHIDQFTADMLGSAE | 346 | P50991 | |
| QGHLFAMESSSGEEY | 2351 | Q9NT68 | |
| HDIFTFLATEVEMQG | 221 | Q12846 | |
| FEHEMSQEGFSAAIT | 346 | P11215 | |
| DFMRQAGEVTFADAH | 126 | Q13243 | |
| YLHGMSEEQETEAFV | 511 | O15042 | |
| EMDADPSFHDSFEQA | 456 | O94911 | |
| SMSSSEIEGNVTFHE | 4646 | Q8IVF2 | |
| TEEFFQTLGDNTHFM | 86 | O60543 | |
| TFDTMDFIAEEGHFP | 71 | Q96M20 | |
| LTLFVSSSQMEDHGF | 71 | Q5SWW7 | |
| AEVKTFMFAGHDTTS | 306 | Q86W10 | |
| VSFSGIVQMDEDTHY | 16 | Q9BXU1 | |
| ETRSLSEHFSGMDAF | 3236 | A4UGR9 | |
| SEHFSGMDAFESQIV | 3241 | A4UGR9 | |
| VFFNDDHTTMTFIGF | 2306 | Q63HN8 | |
| SHLGTEVMVETADNF | 1301 | Q9NRJ4 | |
| EHLSIEDFTQAFGMT | 791 | P09327 | |
| STDVSHQQFMTSGFE | 316 | Q70EK9 | |
| VAQDLAAFHTASSEM | 566 | P52747 | |
| HNTEMTTAAGEAFYT | 1066 | Q9C0E2 | |
| SVLESHESEGSFSMN | 271 | Q86W11 | |
| MASIYSEEGNIEHAF | 46 | O95630 | |
| ATANGHDFQMFSFEE | 511 | P15498 | |
| DSTEFDVVFNAAHML | 741 | Q8N394 | |
| MADHSTTGVRNFEID | 351 | Q8IV35 | |
| REFFSGISHSIMFEE | 2686 | Q9H5I5 | |
| GSFDVADRMFHSVKS | 2661 | Q6ZS81 | |
| VSSLGETYDFDSIMH | 286 | Q9Y6L7 | |
| FNQGMGDSTLEFHSI | 1261 | Q8IWV7 | |
| HGAFATEAVSMAAQS | 751 | Q9C0B7 | |
| DMTEAEQIIFDHFSD | 1301 | Q14997 | |
| MTSAFIDHFGFNDEE | 561 | Q9UPN7 | |
| LEDLVFTQGSHFMAN | 411 | O75643 | |
| SEDEVFDFGDTMVHQ | 706 | Q93050 | |
| DTSGSSFEDMGELHQ | 41 | Q9GZM5 | |
| AFHDDDMDFGDIISS | 156 | Q15643 | |
| GVVMSFTFDSHQLEE | 21 | Q7RTT9 | |
| MAHGSVTFRDVAIDF | 1 | Q9HCL3 | |
| RGFFSEISHSIMFEE | 2456 | Q92508 | |
| AFSHDGQMLVSGSVD | 246 | Q8N9V3 | |
| AQEMIESGFFHESDV | 511 | Q9Y3S1 | |
| MASADELTFHEFEEA | 1 | Q9BWQ6 | |
| IDMDHEASFFGAFLV | 266 | P50591 | |
| HPQEENEMETFGATF | 396 | Q9P2L0 | |
| FFSSMQCAGEVDLHT | 946 | Q8IY18 | |
| AEFAMFSGTHVERDF | 486 | P52888 | |
| ESTHVEFVMFSTDVS | 191 | Q08AF3 | |
| LGTTEFLNMTEHFSE | 381 | O95405 | |
| MSQVTFSDVAIDFSH | 1 | Q9NR11 | |
| GDFLFSSDHLIEMAT | 1061 | O43795 | |
| TDLSGQAFEDAMAEH | 1306 | Q5VTT5 |